0726316-A2 is referenced by 27 patents and cites 4 patents.

The nucleotide sequence of the nonstructural protein NS1 of the influenza virus A/equine 2/Suffolk/89 was determined and found to be 97% identical to that of A/equine 2/Miami/63. A similar level of identity was shown for the deduced NS1 amino acid sequence. The NS1 gene was expressed, in its entirety and in part, as fusion proteins with glutathione S-transferase using, the pGEX-3X expression vector. Antibodies to NS1 protein were detected in serum samples from ponies experimentally infected in influenza virus, but not in animals vaccinated with whole inactivated virus or in unprimed control animals. The antigenic determinants(s) of NS1 protein appear to be located in the C-terminal half of the protein.; The invention makes possible the use of NS1 protein as a diagnostic marker for influenza virus infection in the presence of high levels of circulating antibody to influenza haemagglutinin generated by recent vaccination. Use as a potential vaccine component is also possible. A recombinant fusion protein of glutathione S-transferase and the C-terminal half of NS1 (incorporating amino acid residues 105-230) was tested in an ELISA to detect influenza A virus infection. The detection rate of the ELISA compared to the methods used for the detection of anti-haemagglutinin antibodies was 60-79%. It was able to detect infection against a background of vaccination in samples from experimentally challenged animals and from training yards in which infection following vaccination was suspected.

Expression of the non-structural protein ns1 of influenza virus and detection of anti-ns1 antibody in serum
Application Number
EP19960300681 19960131
Publication Number
0726316 (A2)
Application Date
January 31, 1996
Publication Date
August 14, 1996
Birch Machin Ian
Binns Matthew
Animal Health Trust
G01N 33/569
C12N 15/62
C07K 14/11
C12N 15/44
C12N 15/40
C07K 14/005
C12N 15/44
C07K 14/11
View Original Source Download PDF